
Denzospas-M 80mg/250mg Tablet
Marketer
Capsutab Drugs Pvt Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Denzospas-M 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, Megaspas-80/250 (80mg/250mg tablet). This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing stomach and intestinal muscles and inhibiting pain-inducing chemical signals. Megaspas-80/250 is administered with food, following your doctor's prescribed dosage and duration. Dosage is individualized based on your response and condition. Continue treatment as directed; premature cessation may cause symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach pain, dry mouth, appetite loss, thirst, and heartburn; these are usually temporary. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until effects are known. Alcohol should be avoided due to increased dizziness risk. Disclose pregnancy, pregnancy plans, breastfeeding, or kidney/liver disease to your physician prior to commencing treatment to ensure appropriate dosage.
Primary Ingredients of Denzospas-M 80mg/250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Denzospas-M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Denzospas-M 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Denzospas-M 80mg/250mg Tablet with a meal.
Common Side effects of Denzospas-M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Denzospas-M 80mg/250mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Denzospas-M 80mg/250mg tablets with a meal.
How Denzospas-M 80mg/250mg Tablet works:
Each Denzospas-M 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets and reduces painful abdominal muscle contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory chemicals responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Denzospas-M 80mg/250mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Denzospas-M 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Denzospas-M 80mg/250mg tablets with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Denzospas-M 80mg/250mg Tablets, a potential side effect of this medication due to the risk of dizziness.
KidneyCAUTION
Patients with kidney impairment should use Denzospas-M 80mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Denzospas-M 80mg/250mg tablets are contraindicated in individuals with severe renal dysfunction.
LiverCAUTION
Patients with hepatic impairment should use Denzospas-M 80mg/250mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Denzospas-M 80mg/250mg Tablet :
Should you forget a Denzospas-M 80mg/250mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Denzospas-M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
